Skip to content
PubMed This is a summary of 55 peer-reviewed journal articles Updated
Neurology

Familial Encephalopathy with Neuroserpin Inclusion Bodies (FENIB): A Patient Guide

At a Glance

FENIB is a very rare inherited brain disorder caused by changes in the SERPINI1 gene. It can cause progressive muscle jerks, seizures, and cognitive decline; there is no cure, so seizure treatment, supportive care, and planning ahead are central to care.

Familial Encephalopathy with Neuroserpin Inclusion Bodies (FENIB) is an exceptionally rare, inherited neurodegenerative disorder that impacts both the brain’s electrical activity and its cognitive functions. It is categorized as a conformational disease, a term used for conditions where proteins do not fold into their correct shapes, leading to structural damage within brain cells [1]. For families navigating this diagnosis, it often means entering a world where local medical teams have little to no prior experience, as published cases remain very few in the global medical literature [2].

At a Glance

  • What is known: FENIB is a genetic disorder caused by mutations in the SERPINI1 gene. It causes progressive muscle jerks (myoclonus), seizures, and cognitive decline.
  • What remains uncertain: Because the condition is so rare, there is no set timeline that applies to everyone. The speed of progression and exact symptom order vary widely from person to person.
  • What to do now: Secure a team that includes an epileptologist, connect with genetic counseling, and integrate supportive (palliative) care alongside your active medical treatments right away.

The biological root of the condition lies in the SERPINI1 gene, which normally provides instructions for a protective protein called neuroserpin. In people with FENIB, a genetic mutation causes this protein to become unstable and “sticky,” causing it to clump together inside neurons instead of being released to do its job. These clumps, known as inclusion bodies or Collins bodies, act like a molecular traffic jam, and are associated with structural damage to the neurons [3]. This process leads to a dual challenge: the brain loses the protection of healthy neuroserpin while simultaneously suffering from the toxic buildup of the misfolded protein [4].

This internal damage manifests externally through two core features: progressive myoclonic epilepsy and steady cognitive decline. Families typically notice a combination of sudden, involuntary muscle jerks (myoclonus) and seizures that often prove difficult to control with standard medications. Alongside these physical symptoms, the disease causes a progressive form of dementia, affecting memory, judgment, and the ability to perform daily tasks independently [2]. Because the condition is progressive, the focus of care shifts over time from maintaining independence to providing high levels of daily support as the damage to the nervous system accumulates [5].

While there is currently no cure for FENIB, the path forward is built on compassionate, proactive management. Treatment includes supportive (palliative) care, meaning an active layer of support that begins at diagnosis and runs alongside your seizure treatments to manage symptoms while maximizing comfort and quality of life. This requires a dedicated, multidisciplinary team of specialists—including neurologists, therapists, and palliative care experts—who work together to support both the patient and their caregivers. By focusing on symptom relief and advanced planning, families can navigate the complexities of this condition with a clear focus on dignity and coordinated care [6].

Common questions in this guide

What causes familial encephalopathy with neuroserpin inclusion bodies (FENIB)?
FENIB is caused by an inherited change, or mutation, in the SERPINI1 gene. The change makes the neuroserpin protein unstable, so it clumps inside brain cells and damages them.
What symptoms can FENIB cause?
The main symptoms are progressive involuntary muscle jerks, called myoclonus, seizures, and worsening thinking and memory. Over time, FENIB can cause dementia, impaired judgment, and increasing difficulty with everyday activities.
How quickly does FENIB progress?
There is no single timeline for FENIB. The order and speed of symptoms vary from person to person, but seizures, cognitive decline, and the need for daily support generally increase as the condition progresses.
Is there a cure or treatment for FENIB?
There is currently no cure for FENIB. Care focuses on treating seizures, relieving symptoms, and supporting comfort and quality of life; palliative care can begin at diagnosis while active treatments continue.
Which specialists should be involved in FENIB care?
A neurologist, preferably an epileptologist familiar with progressive myoclonic epilepsy, can help coordinate care. Genetic counseling, therapists, and palliative care specialists can support inherited-risk questions, daily function, symptom relief, planning, and caregivers.
How can families prepare for later changes in FENIB?
Families can discuss safety, quality-of-life goals, and future medical preferences early, while the person with FENIB can take part in decisions. The care team can monitor for new symptoms and help organize practical and emotional support.
Can families join a FENIB patient registry or research network?
Because FENIB is so rare, families can ask their specialist or genetic counselor about patient registries and research networks. Availability and eligibility vary, but participation may help connect families with expertise and improve understanding of the condition.

Get notified when new evidence is published on Familial encephalopathy with neuroserpin inclusion bodies.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (6)
  1. 1

    Progressive myoclonus epilepsy associated with neuroserpin inclusion bodies (neuroserpinosis).

    Roussel BD, Lomas DA, Crowther DC

    Epileptic disorders : international epilepsy journal with videotape 2016; (18(S2)):103-110 doi:10.1684/epd.2016.0847.

    PMID: 27618835
  2. 2

    Role of SERPINI1 pathogenic variants in familial encephalopathy with neuroserpin inclusion bodies: A case report and literature review.

    Yang X, Fang Z, Yan L, et al.

    Seizure 2022; (103()):137-147 doi:10.1016/j.seizure.2022.11.008.

    PMID: 36417830
  3. 3

    Polymerogenic neuroserpin causes mitochondrial alterations and activates NFκB but not the UPR in a neuronal model of neurodegeneration FENIB.

    D'Acunto E, Gianfrancesco L, Serangeli I, et al.

    Cellular and molecular life sciences : CMLS 2022; (79(8)):437 doi:10.1007/s00018-022-04463-3.

    PMID: 35864382
  4. 4

    Neuroserpin polymers cause oxidative stress in a neuronal model of the dementia FENIB.

    Guadagno NA, Moriconi C, Licursi V, et al.

    Neurobiology of disease 2017; (103()):32-44 doi:10.1016/j.nbd.2017.03.010.

    PMID: 28363799
  5. 5

    Frontal deficits and atrophy in a patient with familial encephalopathy with neuroserpin inclusion bodies detected by single-case voxel-based morphometry: a case report.

    Handa H, Sugiyama A, Kaname T, et al.

    BMC neurology 2024; (24(1)):9 doi:10.1186/s12883-023-03511-0.

    PMID: 38166833
  6. 6

    An Inducible Neural Stem Progenitor Cell Model for Testing Therapeutic Interventions Against Neurodegeneration FENIB.

    Giustini A, Maiocchi A, Serangeli I, et al.

    Drug development research 2025; (86(1)):e70041 doi:10.1002/ddr.70041.

    PMID: 39749681

This FENIB page is for informational purposes only and does not constitute medical advice. Your neurologist, epileptologist, genetic counselor, and palliative care team can help interpret your situation and plan individualized care.